Leask, A., Xu, S., Renzoni, E., Bou-Gharios, G., du Bois, R., Abraham, D., & Black, C. (2005). Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.
Citace podle Chicago (17th ed.)Leask, A., S. Xu, E. Renzoni, G. Bou-Gharios, R. du Bois, D. Abraham, a C. Black. Bosentan Alleviates the Pro-fibrotic Phenotype of Lung Scleroderma Fibroblasts: Implications for Treatment of Scleroderma. 2005.
Citace podle MLA (9th ed.)Leask, A., et al. Bosentan Alleviates the Pro-fibrotic Phenotype of Lung Scleroderma Fibroblasts: Implications for Treatment of Scleroderma. 2005.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..